Table 3.
Details of Major Adverse Cardiocerebrovascular Events in the Entire Study Group
No Sleep‐Disordered Breathing (n=115) | Sleep‐Disordered Breathing (n=126) | |
---|---|---|
Major adverse cardiocerebrovascular events | 9 (7.8) | 27 (21.4) |
Death | 3 (2.6) | 10 (7.8) |
Recurrence of acute coronary syndrome | 2 (1.7) | 2 (1.6) |
Nonfatal stroke | 3 (2.6) | 4 (3.2) |
Admission for congestive heart failure | 1 (0.9) | 11 (8.7) |
Data are presented as number of patients (percentage).